Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 22, 2025 10:06 ET | Source: Research and Markets

Osteoporosis Drugs Market Trends Analysis and Growth Forecasts, 2025-2030 by Drug Class (Branded, Generics), Type (Bisphosphates, Parathyroid Hormone Therapy)

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Osteoporosis Drugs Market Size, Share, & Trends Analysis Report by Drug Class (Branded, Generics), Type (Bisphosphates, Parathyroid Hormone...
March 05, 2025 10:50 ET | Source: Research and Markets

Osteoporosis Global Clinical Trials Market Review 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End-Point Status

Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "Osteoporosis_Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...
July 19, 2024 04:34 ET | Source: Research and Markets

Osteoporosis Market Drug Forecast and Analysis Research 2024: A $17.9 Billion Industry by 2033 - Focus on US, France, Germany, Italy, Spain, UK, Japan

Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "Osteoporosis: Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.This report covers the 7MM...
May 29, 2024 07:56 ET | Source: Research and Markets

Osteoporosis Prevalence Set to Escalate by 2033, New Epidemiology Forecast Reveals - Focus on US, France, Germany, Italy, Spain, UK, and Japan

Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Osteoporosis: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. Osteoporosis, a condition identified by...
January 31, 2024 06:57 ET | Source: Research and Markets

Global Osteoporosis Clinical Trials Review 2023: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Osteoporosis - Global Clinical Trials Review, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...
September 15, 2022 06:08 ET | Source: Exactitude Consultancy

Heart Failure Therapeutics Market is expected to generate a revenue of USD 15 billion by 2029 Globally at a 3.8% CAGR

Luton, Bedfordshire, United Kingdom, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has...
May 15, 2022 20:00 ET | Source: FACT.MR

Osteoporosis Therapeutics Market to Top US$ 14 Bn Valuation by 2026: Fact.MR Analysis

United States, Rockville MD, May 15, 2022 (GLOBE NEWSWIRE) -- Demand for osteoporosis therapeutics is anticipated to increase at a CAGR of 2.9% from 2022 to 2026, as per this new analysis by...
August 22, 2016 06:30 ET | Source: Researchmoz Global Pvt Ltd

Osteoporosis Therapeutics in Asia-Pacific (APAC) Markets to 2022: Industry Size, Shares, Trends, Opportunities, Survey and Forecast: ResearchMoz

Albany, NY, Aug. 22, 2016 (GLOBE NEWSWIRE) -- Osteoporosis, the most common metabolic bone disease, is characterized by low bone mass, microarchitectural deterioration of bone tissue, and a...